Senior AI DMPK Lead for Early Drug Discovery

Senior AI DMPK Lead for Early Drug Discovery

Full-Time 49500 - 60500 $ / year (est.) Hybrid
I

At a Glance

  • Tasks: Lead DMPK strategy for innovative drug discovery projects and mentor fellow scientists.
  • Company: Isomorphic Labs, a pioneering company in AI-driven drug design.
  • Benefits: Hybrid working model, competitive salary, and opportunities for professional growth.
  • Other info: Join a dynamic team focused on delivering high-quality drug candidates.
  • Why this job: Shape the future of drug discovery with cutting-edge AI technologies.
  • Qualifications: Experience in DMPK and a passion for mentoring and collaboration.

The predicted salary is between 49500 - 60500 $ per year.

Isomorphic Labs in Australia is seeking a senior DMPK Lead to drive the DMPK strategy for drug discovery projects.

You will work with Preclinical and Clinical teams and contribute to AI-first drug design across modalities.

The role offers hybrid working with in-person collaboration and opportunities to shape state-of-the-art ADME models, PK/PD, and regulatory documentation.

You will mentor scientists and help deliver high-quality candidates.

#J-18808-Ljbffr

Senior AI DMPK Lead for Early Drug Discovery employer: Isomorphic Labs

Isomorphic Labs is an exceptional employer located in Cambridge, MA, where innovation meets collaboration. Our inspiring work culture fosters continuous learning and professional growth, empowering employees to make meaningful contributions towards groundbreaking advancements in drug discovery. With a strong commitment to diversity and inclusion, we offer a supportive environment that values unique perspectives, ensuring every team member thrives while working on life-changing solutions.

I

Contact Details:

Isomorphic Labs Recruitment Team

We think you need these skills to ace Senior AI DMPK Lead for Early Drug Discovery

DMPK Strategy Development
AI-First Drug Design
ADME Modelling
PK/PD Analysis
Regulatory Documentation
Mentoring Skills
Collaboration with Preclinical Teams